Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Development of Cancer-Specific MRS Biomarkers in Malignant Gliomas

NCT02388659 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.

NCT NCT02388659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02388659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Development of Cancer-Specific MRS Biomarkers in Malignant Gliomas
Lead sponsor
University of Texas Southwestern Medical Center
Phase
Observational
Overall status
Completed
Start date
February 28, 2014
Completion date
December 31, 2021
Enrollment
142 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

astrocytomas, malignant gliomas, oligodendrogliomas